Skip to main content

DESCIFRANDO LAS FUNCIONES Y ONTOGENIA DE LAS CELULAS MADRE/ PROGENITORAS MESENQUIMALES EMBRIONARIAS

BFU2012-35892

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Investigación, Desarrollo e Innovación
Beneficiary centre CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Sox17 controls emergence and remodeling of Nestin-expressing coronary vessels

  • González Hernández, Sara
  • Gómez, Manuel J.
  • Sánchez Cabo, Fátima
  • Méndez Ferrer, Simón
  • Muñoz Cánoves, Pura, 1962-
  • Isern, Joan
Rationale: The molecular mechanisms underlying the formation of coronary arteries during development and during cardiac neovascularization after injury are poorly understood. However, a detailed description of the relevant signaling pathways and functional transcription factors regulating these processes is still incomplete. Objective: The goal of this study is to identify novel cardiac transcriptional mechanisms of coronary angiogenesis and vessel remodeling by defining the molecular signatures of coronary vascular endothelial cells (EC) during these complex processes. Methods and Results: We demonstrate that Nes-gfp and Nes-CreERT2 transgenic mouse lines are novel tools for studying the emergence of coronary endothelium and targeting sprouting coronary vessels (but not ventricular endocardium) during development. Furthermore, we identify Sox17 as a critical transcription factor upregulated during the sprouting and remodeling of coronary vessels, visualized by a specific neural enhancer from the Nestin gene that is strongly induced in developing arterioles. Functionally, genetic inducible endothelial deletion of Sox17 causes deficient cardiac remodeling of coronary vessels, resulting in improper coronary artery formation. Conclusions: We demonstrated that Sox17 transcription factor regulates the transcriptional activation of Nestin's enhancer in developing coronary vessels while its genetic deletion leads to inadequate coronary artery formation. These findings identify Sox17 as a critical regulator for the remodeling of coronary vessels in the developing heart., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad (BFU2012-35892 and Ramón y Cajal Program grant RYC-2011-09209 to J.I.), and FPIMINECO13 fellowship (BES-2013-065514) to S.G.H. Additionally, S.M.-F laboratory received funding from Plan Nacional grant SAF-2011-30308, Ramón y Cajal Program grant RYC-2009-04703, Spanish Cell Therapy Network TerCel, Marie Curie Career Integration Program grant FP7-PEOPLE-2011-RG-294096, ConSEPOC-Comunidad de Madrid grant S2010/BMD-2542 and Howard Hughes International Early Career Scientist grant. This study was also supported by Intramural grants from the Severo Ochoa program (IGP-SO), Fundació La Marató de TV3 (120/C/2015-20153032), and grant RTI2018-095497-B-I00 from MCIU to A.H.; and to MINECO RTI2018-096068, AFM, MDA, LaCaixa-HR17-00040, UPGRADE-H2020-825825 grants and ERC Advanced Grant-741538 to PMC. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The UPF is a María de Maeztu Unit of Excellence (MDM-2014-0370).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1

  • Sainz de Aja, Julio
  • Menchero, Sergio
  • Rollan, Isabel
  • Barral, Antonio
  • Tiana, Maria
  • Jawaid, Wajid
  • Cossio, Itziar
  • Alvarez, Alba
  • Carreño-Tarragona, Gonzalo
  • Badia-Careaga, Claudio
  • Nichols, Jennifer
  • Göttgens, Berthold
  • Isern, Joan
  • Manzanares, Miguel
Includes supplementary materials: online appendix; replication data, Progenitors of the first hematopoietic cells in the mouse arise in the early embryo from Brachyury-positive multipotent cells in the posterior-proximal region of the epiblast, but the mechanisms that specify primitive blood cells are still largely unknown. Pluripotency factors maintain uncommitted cells of the blastocyst and embryonic stem cells in the pluripotent state. However, little is known about the role played by these factors during later development, despite being expressed in the postimplantation epiblast. Using a dual transgene system for controlled expression at postimplantation stages, we found that Nanog blocks primitive hematopoiesis in the gastrulating embryo, resulting in a loss of red blood cells and downregulation of erythropoietic genes. Accordingly, Nanog-deficient embryonic stem cells are prone to erythropoietic differentiation. Moreover, Nanog expression in adults prevents the maturation of erythroid cells. By analysis of previous data for NANOG binding during stem cell differentiation and CRISPR/Cas9 genome editing, we found that Tal1 is a direct NANOG target. Our results show that Nanog regulates primitive hematopoiesis by directly repressing critical erythroid lineage specifiers., This work was supported by the Spanish government (grant BFU2014-54608-P and BFU2017-84914-P to MM; grants RYC-2011-09209 and BFU-2012-35892 to JI). The Gottgens and Nichols laboratories are supported by core funding from the Wellcome Trust and MRC to the Wellcome and MRC Cambridge Stem Cell Institute. The CNIC is supported by the Spanish Ministry of Science, Innovation and Universities (MINECO) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Sox17 controls emergence and remodeling of Nestin-expressing coronary vessels

  • González Hernández, Sara
  • Gómez, Manuel J.
  • Sánchez Cabo, Fátima
  • Méndez Ferrer, Simón
  • Muñoz Cánoves, Pura, 1962-
  • Isern, Joan
Rationale: The molecular mechanisms underlying the formation of coronary arteries during development and during cardiac neovascularization after injury are poorly understood. However, a detailed description of the relevant signaling pathways and functional transcription factors regulating these processes is still incomplete. Objective: The goal of this study is to identify novel cardiac transcriptional mechanisms of coronary angiogenesis and vessel remodeling by defining the molecular signatures of coronary vascular endothelial cells (EC) during these complex processes. Methods and Results: We demonstrate that Nes-gfp and Nes-CreERT2 transgenic mouse lines are novel tools for studying the emergence of coronary endothelium and targeting sprouting coronary vessels (but not ventricular endocardium) during development. Furthermore, we identify Sox17 as a critical transcription factor upregulated during the sprouting and remodeling of coronary vessels, visualized by a specific neural enhancer from the Nestin gene that is strongly induced in developing arterioles. Functionally, genetic inducible endothelial deletion of Sox17 causes deficient cardiac remodeling of coronary vessels, resulting in improper coronary artery formation. Conclusions: We demonstrated that Sox17 transcription factor regulates the transcriptional activation of Nestin's enhancer in developing coronary vessels while its genetic deletion leads to inadequate coronary artery formation. These findings identify Sox17 as a critical regulator for the remodeling of coronary vessels in the developing heart., This work was supported by grants from the Spanish Ministerio de Economía y Competitividad (BFU2012-35892 and Ramón y Cajal Program grant RYC-2011-09209 to J.I.), and FPIMINECO13 fellowship (BES-2013-065514) to S.G.H. Additionally, S.M.-F laboratory received funding from Plan Nacional grant SAF-2011-30308, Ramón y Cajal Program grant RYC-2009-04703, Spanish Cell Therapy Network TerCel, Marie Curie Career Integration Program grant FP7-PEOPLE-2011-RG-294096, ConSEPOC-Comunidad de Madrid grant S2010/BMD-2542 and Howard Hughes International Early Career Scientist grant. This study was also supported by Intramural grants from the Severo Ochoa program (IGP-SO), Fundació La Marató de TV3 (120/C/2015-20153032), and grant RTI2018-095497-B-I00 from MCIU to A.H.; and to MINECO RTI2018-096068, AFM, MDA, LaCaixa-HR17-00040, UPGRADE-H2020-825825 grants and ERC Advanced Grant-741538 to PMC. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The UPF is a María de Maeztu Unit of Excellence (MDM-2014-0370).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1

  • Sainz de Aja, Julio
  • Menchero, Sergio
  • Rollan, Isabel
  • Barral, Antonio
  • Tiana, Maria
  • Jawaid, Wajid
  • Cossio, Itziar
  • Alvarez, Alba
  • Carreño-Tarragona, Gonzalo
  • Badia-Careaga, Claudio
  • Nichols, Jennifer
  • Göttgens, Berthold
  • Isern, Joan
  • Manzanares, Miguel
Includes supplementary materials: online appendix; replication data, Progenitors of the first hematopoietic cells in the mouse arise in the early embryo from Brachyury-positive multipotent cells in the posterior-proximal region of the epiblast, but the mechanisms that specify primitive blood cells are still largely unknown. Pluripotency factors maintain uncommitted cells of the blastocyst and embryonic stem cells in the pluripotent state. However, little is known about the role played by these factors during later development, despite being expressed in the postimplantation epiblast. Using a dual transgene system for controlled expression at postimplantation stages, we found that Nanog blocks primitive hematopoiesis in the gastrulating embryo, resulting in a loss of red blood cells and downregulation of erythropoietic genes. Accordingly, Nanog-deficient embryonic stem cells are prone to erythropoietic differentiation. Moreover, Nanog expression in adults prevents the maturation of erythroid cells. By analysis of previous data for NANOG binding during stem cell differentiation and CRISPR/Cas9 genome editing, we found that Tal1 is a direct NANOG target. Our results show that Nanog regulates primitive hematopoiesis by directly repressing critical erythroid lineage specifiers., This work was supported by the Spanish government (grant BFU2014-54608-P and BFU2017-84914-P to MM; grants RYC-2011-09209 and BFU-2012-35892 to JI). The Gottgens and Nichols laboratories are supported by core funding from the Wellcome Trust and MRC to the Wellcome and MRC Cambridge Stem Cell Institute. The CNIC is supported by the Spanish Ministry of Science, Innovation and Universities (MINECO) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).